Integrative study of pulmonary microbiome, transcriptome and clinical outcomes in Mycoplasma pneumoniae pneumonia
Xia Huang1, Yingying Luo1, Jing Wang1
1Department of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, 210008, China.
Background:
This study aimed to investigate the interactions among three core elements of respiratory infection-pathogen, lung microbiome, and host response-and their avocation with the severity and outcomes of Mycoplasma pneumoniae pneumonia (MPP) in children.
Methods:
We prospectively collected bronchoalveolar lavage fluid from a cohort of 41 children with MPP, including general MPP (GMPP) and complicated MPP (CMPP), followed by microbiome and transcriptomic analyses to characterize the association among pathogen, lung microbiome, and host response and correlate it with the clinical features and outcomes.
Results:
The lung microbiome of patients with CMPP had an increased relative abundance of Mycoplasma pneumoniae (MP) and reduced alpha diversity, with 76 differentially expressed species. Host gene analysis revealed a key module associated with neutrophil function and several inflammatory response pathways. Patients with a high relative abundance of MP, manifested by a specific lung microbiome and host response type, were more prone to CMPP and had a long imaging recovery time.
Conclusion:
Patients with CMPP have a more disrupted lung microbiome than those with GMPP. MP, lung microbiome, and host response interacts with each other and are closely related to disease severity and outcomes in children with MPP.
Insights
In children, complicated Mycoplasma pneumoniae pneumonia (MPP) shows a disrupted lung microbiome. Interactions between the pathogen, lung microbiome, and host response impact MPP severity and recovery.
Area of Science:
- Pediatric Respiratory Medicine
- Microbiome Research
- Immunology
Background:
- Mycoplasma pneumoniae pneumonia (MPP) is a common childhood respiratory infection.
- Understanding the interplay between pathogen, lung microbiome, and host response is crucial for managing MPP.
- Distinct clinical presentations, general MPP (GMPP) and complicated MPP (CMPP), suggest underlying biological differences.
Purpose of the Study:
- To investigate the interactions among pathogen, lung microbiome, and host response in pediatric MPP.
- To correlate these interactions with disease severity and clinical outcomes.
- To differentiate these elements between general and complicated forms of MPP.
Main Methods:
- Prospective collection of bronchoalveolar lavage fluid from 41 children with MPP.
- Microbiome and transcriptomic analyses of lung fluid.
- Correlation of findings with clinical features and outcomes, distinguishing between GMPP and CMPP.
Main Results:
- Complicated MPP (CMPP) exhibited an increased relative abundance of Mycoplasma pneumoniae (MP) and reduced lung microbiome diversity.
- Host gene analysis identified key modules related to neutrophil function and inflammatory pathways.
- A specific lung microbiome and host response profile associated with high MP abundance correlated with CMPP and prolonged imaging recovery.
Conclusions:
- Patients with CMPP present with a more disrupted lung microbiome compared to GMPP.
- Interactions between MP, the lung microbiome, and host response are intrinsically linked to MPP severity and outcomes in children.
- These findings highlight potential therapeutic targets for improving pediatric MPP management.
More Related Videos
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
07:43A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
Published on: September 28, 2016
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology
